Seattle Genetics Inc. Q4 Profit Rises

Seattle Genetics Inc. (SGEN) released earnings for its fourth quarter that rose from the same period last year.

The company's bottom line came in at $167.10 million, or $0.90 per share. This compares with $25.83 million, or $0.14 per share, in last year's fourth quarter.

Analysts had expected the company to earn $0.86 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 107.5% to $601.29 million from $289.80 million last year.

Seattle Genetics Inc. earnings at a glance:

-Earnings (Q4): $167.10 Mln. vs. $25.83 Mln. last year.
-EPS (Q4): $0.90 vs. $0.14 last year.
-Analysts Estimate: $0.86
-Revenue (Q4): $601.29 Mln vs. $289.80 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT